Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-3248-2026

Brand Name: Pearle Vision 1 day Product Name: (somofilcon A) Contact Lens Recall

Brand Name: Pearle Vision 1 day Product Name: (somofilcon A) Contact Lens Model/Catalog Number: Pearle Vision 1 day

FDA recall Class II

Ongoing

FDA lists this Class II recall for Brand Name: Pearle Vision 1 day Product Name: (somofilcon A) Contact Lens. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-3248-2026
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
Aug 12, 2026
FDA report date
Sep 30, 2026
Quantity in commerce
3060
Distribution
See key details
FDA cause
Process control

What is being recalled?

Brand Name: Pearle Vision 1 day Product Name: (somofilcon A) Contact Lens Model/Catalog Number: Pearle Vision 1 day

The retrieved code information does not contain explicit model/GTIN pairs that this publication can reliably map.

Search FDA identifier text

Search a model, catalog, lot or UDI value exactly as printed in FDA’s product description or code information.

This search checks only the FDA product description and code information displayed on this page. It does not decode a UDI, normalize GTIN lengths or establish a relationship between separately listed codes.

FDA code information

Pearle Vision 1 day; Carton Lot # 11727620152030; Blister Lot # CB132348;

View the original FDA recall notice

Why was this product recalled?

A small number of lenses within the affected lot are of the incorrect power.

What actions did CooperVision, Inc. take?

On August 24, 2026 URGENT MEDICAL DEVICE CORRECTION letters were sent to customers. Actions to be taken: 1. Please stop any further distribution of products from the designated lot number. 2. Dispose of the affected product in your inventory or that is returned to you. 3. Within the next five (5) business days, please complete the response form provided and return it. If you have no lenses from these specified lots, please put 0 in Quantity and return the form. 4. We recommend authorized distributors contact your accounts, and Eye Care Practitioners contact your patients who have received the affected product, with the enclosed Customer Communication Letter . 5. Please instruct any patients to return any affected product to their Eye Care Practitioner or purchase location for replacement or credit.

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology